Faculty Profiles - KANAZAWA Kenya

Papers - KANAZAWA Kenya

Division display241 - 260 of about 540／ All the affair displays >>

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology 26 ( 3 ) 515 - 522 2021.3（ ISSN:1341-9625 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy 14 325 - 334 2021（ ISSN:1178-6965 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy 14 325 - 334 2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology 99 ( 9 ) 562 - 570 2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy 14 325 - 334 2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology 99 ( 9 ) 562 - 570 2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy 14 325 - 334 2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology 99 ( 9 ) 562 - 570 2021（ ISSN:0030-2414 ）

　 PREV - NEXT 　

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27